CHARACTERIZATION OF 2 HUMAN MAMMARY CARCINOMAS, MT-1 AND MT-3, SUITABLE FOR INVIVO TESTING OF ETHER LIPIDS AND THEIR DERIVATIVES

被引:42
作者
NAUNDORF, H
REWASOWA, EC
FICHTNER, I
BUTTNER, B
BECKER, M
GORLICH, M
机构
[1] MAX DELBRUCK CENTRUM MOLEC MED,BUCH,GERMANY
[2] ACAD MED SCI,CANC RES CTR,MOSCOW,USSR
关键词
EXPERIMENTAL CHEMOTHERAPY; ETHER LIPIDS; HUMAN MAMMARY CARCINOMA; NUDE MICE;
D O I
10.1007/BF01831480
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The human mammary carcinomas MT-1 and MT-3 originate from surgical material and were transplanted in nude mice. Both tumors have been classified as estradiol- and progesterone receptor-negative. Therapeutic doses of hormones and anti-hormones remained without growth inhibitory effect. MT-1 and MT-3 proved to be sensitive to conventional cytostatic drugs used for treatment of mammary carcinomas; striking is their sensitivity to ether lipids. Therefore, they are considered suitable tumor models for this class of substances.
引用
收藏
页码:87 / 95
页数:9
相关论文
共 31 条
  • [1] ACKERMANN E, 1988, ALLERG IMMUNOL LEIPZ, V34, P196
  • [2] AHMED SA, 1985, AM J PATHOL, V121, P531
  • [3] ALUNNIBISTOCCHI G, 1990, FARMACO, V45, P499
  • [4] HUMAN MAMMARY CANCERS IN NU-NU-MICE - MODEL FOR TESTING IN RESEARCH AND CLINIC
    BASTERT, G
    SCHMIDTMATTHIESEN, H
    MICHEL, RT
    FORTMEYER, HP
    STURM, R
    NORD, D
    GERNER, R
    [J]. KLINISCHE WOCHENSCHRIFT, 1977, 55 (02): : 83 - 84
  • [5] BASTERT G, 1981, THYMUSAPLASTIC NUDE, P157
  • [6] AN ANTAGONIST TO PLATELET ACTIVATING FACTOR COUNTERACTS THE TUMORICIDAL ACTION OF ALKYL LYSOPHOSPHOLIPIDS
    BAZILL, GW
    DEXTER, TM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (02) : 374 - 377
  • [7] COLOWEW JN, 1978, WESTNIK AMN CCC
  • [8] HEXADECYLPHOSPHOCHOLINE - A NEW AND SELECTIVE ANTITUMOR DRUG
    EIBL, H
    UNGER, C
    [J]. CANCER TREATMENT REVIEWS, 1990, 17 (2-3) : 233 - 242
  • [9] FOGH J, 1982, 3RD P INT WORKSH NUD, P447
  • [10] HETEROTRANSPLANTATION OF HUMAN BREAST CARCINOMAS IN NUDE-MICE - CORRELATION BETWEEN SUCCESSFUL HETEROTRANSPLANTS, POOR PROGNOSIS AND AMPLIFICATION OF THE HER-2 NEU ONCOGENE
    GIOVANELLA, BC
    VARDEMAN, DM
    WILLIAMS, LJ
    TAYLOR, DJ
    DEIPOLYI, PD
    GREEFF, PJ
    STEHLIN, JS
    ULLRICH, A
    CAILLEAU, R
    SLAMON, DJ
    GARY, HE
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (01) : 66 - 71